HCW Biologics HCWB Ratios (2020-2025)

NASDAQ HCWB
$2.10 -0.20 (-8.70%)
As of: Aug 20, 2026 · 3:59 PM EDT
Ratios Jun2020 Sep2020 Dec2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter)
57.40%36.74%20.00%20.00%29.92%19.33%20.49%19.08%54.56%29.15%20.00%20.00%20.00%20.00%20.00%20.00%
EBT Margin (Quarter)
-60.78%-811.10%-231.67%-429.49%-13,022.01%-1,013.24%-806.22%-813.20%-665.09%-2,471.61%-917.77%-841.77%-43,862.27%-56,378.49%-21,909.50%-17,304.52%
EBIT Margin (Quarter)
-60.33%-773.36%-222.20%-422.45%-12,798.92%-724.22%-595.23%-813.31%-665.09%-2,445.81%-864.06%-797.23%-38,811.49%-52,886.67%-21,095.26%-16,519.15%
EBITDA Margin (Quarter)
-60.33%-773.36%-222.20%-422.45%-12,798.92%-724.22%-595.23%-813.31%-665.09%-2,445.81%-864.06%-797.23%-38,811.49%-52,886.67%-21,095.26%-16,519.15%
Operating Margin (Quarter)
-60.33%-773.36%-222.20%-422.45%-12,798.92%-724.22%-595.23%-813.31%-665.09%-2,445.81%-864.06%-797.23%-38,811.49%-52,886.67%-21,095.26%-16,519.15%
Net Margin (Quarter)
-65.99%-773.25%-231.67%-429.49%-13,022.01%-1,013.24%-806.22%-813.20%-665.09%-2,469.11%-915.12%-854.42%-43,862.27%-184,450.82%-29,183.24%-12,832.14%
FCF Margin (Quarter)
-51.83%-587.29%-692.15%478.34%-8,686.61%-1,806.14%-683.16%-456.17%-514.43%-449.39%-694.98%-746.77%-69,375.24%-50,111.50%-20,760.87%-12,423.24%
Efficiency
Assets Average (Quarter)
34.72M54.96M52.24M49.18M49.38M49.08M45.17M41.51M37.55M32.07M29.47M28.62M26.69M28.40M28.26M27.60M27.18M24.98M
Invested Capital (Quarter)
38.27M0.07M0.10M0.12M0.12M0.12M6.34M6.31M6.23M6.42M6.81M6.81M
Asset Utilization Ratio (Quarter)
0.060.070.110.140.080.090.080.090.130.140.130.090.050.030.020.00
Leverage & Solvency
Interest Coverage Ratio (Quarter)
52.74-76.42-113.67-2.77-135.03-20.49-23.46-59.99-57.37-2.51-2.820.01M-94.80-16.09-17.90-7.68-15.15-25.91-21.03
Debt Ratio (Quarter)
0.130.950.150.160.180.220.280.370.480.450.530.230.270.28
Times Interest Earned (Quarter)
52.74-76.42-113.67-2.77-135.03-20.49-23.46-59.99-57.37-2.51-2.820.01M-94.80-16.09-17.90-7.68-15.15-25.91-21.03
Valuation
Enterprise Value (Quarter)
24.36M27.00M-40.09M-36.71M-59.98M-32.39M-34.46M-32.04M-28.24M-17.36M-10.00M-3.60M-4.10M-0.08M-0.08M-4.67M-1.11M-2.44M-1.10M-1.95M
Return Ratios
Return on Sales (Quarter)
-0.01%-0.08%-0.02%-0.04%-1.30%-0.10%-0.08%-0.08%-0.07%-0.25%-0.09%-0.08%-4.39%-5.64%-2.19%-1.73%
Return on Capital Employed (Quarter)
-25.35%-25.40%-23.29%-26.22%-26.60%-32.69%-45.65%-52.90%-64.16%-110.29%-173.43%-711.89%1,098.72%2,390.68%-2,139.05%-1,631.83%-3,739.81%-336.32%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%-0.01%